Page last updated: 2024-12-07

bromoacetaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bromoacetaldehyde: RN given refers to unlabeled cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID105131
CHEBI ID34263
SCHEMBL ID102758
MeSH IDM0115199

Synonyms (23)

Synonym
2-bromo-acetaldehyde
monobromoacetaldehyde
brn 0969223
acetaldehyde, bromo-
bromoacetaldehyde
2-bromoacetaldehyde
17157-48-1
A18304
AKOS006279610
bromo-acetaldehyde
tgb3vxq7jv ,
unii-tgb3vxq7jv
4-01-00-03151 (beilstein handbook reference)
SCHEMBL102758
NMPVEAUIHMEAQP-UHFFFAOYSA-N
2-bromo-ethanone
alpha-bromoacetaldehyde
bromoacetaldehye
CHEBI:34263
DTXSID1020196
Q27115951
EN300-78793
mfcd01733508

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results suggest that dibromoalkane-induced cell lysis is due to lipid peroxidation as well as cytochrome P450-dependent formation of toxic bromoaldehydic metabolites which can bind with cellular macromolecules."( Molecular mechanisms of dibromoalkane cytotoxicity in isolated rat hepatocytes.
Khan, S; O'Brien, PJ; Sood, C, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organobromine compoundA compound containing at least one carbon-bromine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (64.71)18.7374
1990's10 (29.41)18.2507
2000's2 (5.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.99 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.05 (4.65)
Search Engine Demand Index81.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.86%)4.05%
Observational0 (0.00%)0.25%
Other34 (97.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]